NTHL1 and cancer: In conclusion, the current results indicate that NTHL1 p.Q90* allele is unlikely to be a significant contributor to breast cancer risk at the population level and that the risk is not increased in heterozygous carriers, which is in line with results obtained from other cancer types (Belhadj et al., 2019).